zgc:110272 antikoerper, mp:zf637-1-000774 antikoerper, BCCIP antikoerper, DKFZp459K2416 antikoerper, MGC82792 antikoerper, tok-1 antikoerper, MGC89311 antikoerper, TOK-1 antikoerper, TOK1 antikoerper, 1110013J05Rik antikoerper, BRCA2 and CDKN1A interacting protein antikoerper, BRCA2 and CDKN1A interacting protein L homeolog antikoerper, BCCIP antikoerper, bccip antikoerper, bccip.L antikoerper, Bccip antikoerper
Hintergrund
This gene product was isolated on the basis of its interaction with BRCA2 and p21 proteins. It is an evolutionarily conserved nuclear protein with multiple interacting domains. The N-terminal half shares moderate homology with regions of calmodulin and M-calpain, suggesting that it may also bind calcium. Functional studies indicate that this protein may be an important cofactor for BRCA2 in tumor suppression, and a modulator of CDK2 kinase activity via p21. This protein has also been implicated in the regulation of BRCA2 and RAD51 nuclear focus formation, double-strand break-induced homologous recombination, and cell cycle progression. Multiple transcript variants encoding different isoforms have been described for this gene.